• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制因子miR-613通过抑制M2巨噬细胞极化减轻非小细胞肺癌细胞

Tumor Suppressor miR-613 Alleviates Non-Small Cell Lung Cancer Cell via Repressing M2 Macrophage Polarization.

作者信息

Yang Mingjun, Zhou Wen, Xu Mingming, Han Xiao, Shi Yanyan, Shi Min, Wang Zhipeng

机构信息

Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, No. 20, Xisi Road, Nantong, Jiangsu 226001, China.

Department of Thoracic Surgery, Haimen People's Hospital, No. 1201, Beijing Road, Nantong, Jiangsu 226001, China.

出版信息

J Oncol. 2023 Feb 16;2023:2311231. doi: 10.1155/2023/2311231. eCollection 2023.

DOI:10.1155/2023/2311231
PMID:36844868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9950322/
Abstract

BACKGROUND

Non-small cell lung cancer (NSCLC) is a crucial crux of cancer-related death, and M2 macrophage polarization facilitates NSCLC development. MicroRNA-613 (miR-613) is a tumor suppressor. This research aimed to clarify the miR-613 function in NSCLC and its impact on M2 macrophage polarization. miR-613 expressions in NSCLC tissues and cells were evaluated using quantitative real-time PCR. For miR-613 function in NSCLC, cell proliferation analysis, cell counting kit-8, flow cytometry, western blot, transwell, and wound-healing were conducted. Meanwhile, the miR-613 impact on M2 macrophage polarization was assessed by the NSCLC models. miR-613 was lessened in NSCLC cells and tissues. It was corroborated that miR-613 overexpression retrained NSCLC cell proliferation, invasion, and migration but facilitated cell apoptosis. Moreover, miR-613 overexpression restrained NSCLC development by repressing M2 macrophage polarization.

CONCLUSION

Tumor suppressor miR-613 ameliorated NSCLC by restraining M2 macrophage polarization.

摘要

背景

非小细胞肺癌(NSCLC)是癌症相关死亡的关键症结所在,M2巨噬细胞极化促进NSCLC发展。微小RNA-613(miR-613)是一种肿瘤抑制因子。本研究旨在阐明miR-613在NSCLC中的功能及其对M2巨噬细胞极化的影响。采用定量实时聚合酶链反应评估NSCLC组织和细胞中miR-613的表达。对于miR-613在NSCLC中的功能,进行了细胞增殖分析、细胞计数试剂盒-8检测、流式细胞术、蛋白质免疫印迹法、Transwell实验和伤口愈合实验。同时,通过NSCLC模型评估miR-613对M2巨噬细胞极化的影响。NSCLC细胞和组织中miR-613表达降低。证实miR-613过表达可抑制NSCLC细胞增殖、侵袭和迁移,但促进细胞凋亡。此外,miR-613过表达通过抑制M2巨噬细胞极化来抑制NSCLC发展。

结论

肿瘤抑制因子miR-613通过抑制M2巨噬细胞极化改善NSCLC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/6aa949dfeedc/JO2023-2311231.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/3d81acf6113a/JO2023-2311231.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/761e346ad55d/JO2023-2311231.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/32089e901059/JO2023-2311231.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/ec3bd24d0164/JO2023-2311231.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/69e75fc92fb7/JO2023-2311231.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/6aa949dfeedc/JO2023-2311231.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/3d81acf6113a/JO2023-2311231.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/761e346ad55d/JO2023-2311231.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/32089e901059/JO2023-2311231.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/ec3bd24d0164/JO2023-2311231.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/69e75fc92fb7/JO2023-2311231.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7905/9950322/6aa949dfeedc/JO2023-2311231.006.jpg

相似文献

1
Tumor Suppressor miR-613 Alleviates Non-Small Cell Lung Cancer Cell via Repressing M2 Macrophage Polarization.肿瘤抑制因子miR-613通过抑制M2巨噬细胞极化减轻非小细胞肺癌细胞
J Oncol. 2023 Feb 16;2023:2311231. doi: 10.1155/2023/2311231. eCollection 2023.
2
Tumor Cell-Derived Exosomal miR-770 Inhibits M2 Macrophage Polarization Targeting MAP3K1 to Inhibit the Invasion of Non-small Cell Lung Cancer Cells.肿瘤细胞衍生的外泌体miR-770通过靶向MAP3K1抑制M2巨噬细胞极化,从而抑制非小细胞肺癌细胞的侵袭。
Front Cell Dev Biol. 2021 Jun 14;9:679658. doi: 10.3389/fcell.2021.679658. eCollection 2021.
3
Comprehensive Integrative Analysis Reveals the Association of with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment.全面综合分析揭示与肺癌微环境中巨噬细胞浸润和极化的关联。
Cells. 2021 Aug 14;10(8):2091. doi: 10.3390/cells10082091.
4
Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis.lncRNA PCAT6 的敲低通过 miR-326/KLF1 轴抑制巨噬细胞 M2 极化抑制非小细胞肺癌细胞的生长。
Bioengineered. 2022 May;13(5):12834-12846. doi: 10.1080/21655979.2022.2076388.
5
Tumor cell-derived exosomal microRNA-146a promotes non-small cell lung cancer cell invasion and proliferation by inhibiting M1 macrophage polarization.肿瘤细胞衍生的外泌体微小RNA-146a通过抑制M1巨噬细胞极化促进非小细胞肺癌细胞的侵袭和增殖。
Ann Transl Med. 2022 Dec;10(24):1307. doi: 10.21037/atm-22-5565.
6
Long non-coding RNA LINC00511 promotes proliferation, invasion, and migration of non-small cell lung cancer cells by targeting miR-625-5p/GSPT1.长链非编码RNA LINC00511通过靶向miR-625-5p/GSPT1促进非小细胞肺癌细胞的增殖、侵袭和迁移。
Transl Cancer Res. 2021 Dec;10(12):5159-5173. doi: 10.21037/tcr-21-1468.
7
LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.长链非编码 RNA GNAS-AS1 通过调控 miR-433-3p/GATA3 轴促进 M2 型巨噬细胞极化进而促进 ER+乳腺癌细胞的进展。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200626.
8
MiR-216b targets CPEB4 to suppress colorectal cancer progression through inhibiting IL-10-mediated M2 polarization of tumor-associated macrophages.微小RNA-216b靶向CPEB4,通过抑制白细胞介素-10介导的肿瘤相关巨噬细胞M2极化来抑制结直肠癌进展。
Am J Transl Res. 2022 Nov 15;14(11):8129-8145. eCollection 2022.
9
LINC00240/miR-155 axis regulates function of trophoblasts and M2 macrophage polarization via modulating oxidative stress-induced pyroptosis in preeclampsia.LINC00240/miR-155 轴通过调节子痫前期氧化应激诱导的细胞焦亡调节滋养细胞和 M2 巨噬细胞极化的功能。
Mol Med. 2022 Sep 24;28(1):119. doi: 10.1186/s10020-022-00531-3.
10
Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.长链非编码 RNA MALAT1 通过 miR-374b-5p/SRSF7 轴调控非小细胞肺癌的增殖、凋亡、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1853-1862. doi: 10.26355/eurrev_202002_20363.

引用本文的文献

1
Upregulation of ARHGAP18 by miR-613 Inhibits Cigarette Smoke Extract-Induced Apoptosis and Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells.miR-613介导的ARHGAP18上调抑制香烟烟雾提取物诱导的支气管上皮细胞凋亡和上皮-间质转化
Int J Chron Obstruct Pulmon Dis. 2025 Jul 18;20:2525-2537. doi: 10.2147/COPD.S524723. eCollection 2025.
2
Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2/STAT3 Signaling Pathway.敲低HM13通过抑制JAK2/STAT3信号通路抑制非小细胞肺癌细胞的转移、增殖和M2巨噬细胞极化。
Appl Biochem Biotechnol. 2025 Jan;197(1):570-586. doi: 10.1007/s12010-024-05054-7. Epub 2024 Aug 29.
3

本文引用的文献

1
Long non-coding RNA NUT family member 2A-antisense RNA 1 sponges microRNA-613 to increase the resistance of gastric cancer cells to matrine through regulating oxidative stress and vascular endothelial growth factor A.长链非编码 RNA NUT 家族成员 2A-反义 RNA 1 通过海绵吸附 microRNA-613 增加胃癌细胞对苦参碱的耐药性,通过调节氧化应激和血管内皮生长因子 A。
Aging (Albany NY). 2022 Jun 27;14(12):5153-5162. doi: 10.18632/aging.204135.
2
Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1.抑癌 miR-613 通过靶向 GJA1 诱导非小细胞肺癌细胞对顺铂的敏感性。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.12024. Epub 2021 Mar 24.
3
Chrysin Inhibits TAMs-Mediated Autophagy Activation via CDK1/ULK1 Pathway and Reverses TAMs-Mediated Growth-Promoting Effects in Non-Small Cell Lung Cancer.
白杨素通过CDK1/ULK1途径抑制肿瘤相关巨噬细胞介导的自噬激活,并逆转肿瘤相关巨噬细胞介导的非小细胞肺癌生长促进作用。
Pharmaceuticals (Basel). 2024 Apr 17;17(4):515. doi: 10.3390/ph17040515.
Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Muscle Toxicity through Counteracting Pyroptosis.
干细胞衍生的外泌体通过对抗细胞焦亡改善阿霉素诱导的肌肉毒性。
Pharmaceuticals (Basel). 2020 Dec 9;13(12):450. doi: 10.3390/ph13120450.
4
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer.间变性淋巴瘤激酶重排非小细胞肺癌的治疗策略。
Drugs. 2021 Jan;81(1):87-100. doi: 10.1007/s40265-020-01445-2.
5
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives.晚期非小细胞肺癌的新型靶向治疗:文献综述与未来展望
J Clin Med. 2020 Nov 3;9(11):3543. doi: 10.3390/jcm9113543.
6
New insights into long non-coding RNAs in non-small cell lung cancer.长非编码 RNA 在非小细胞肺癌中的新认识。
Biomed Pharmacother. 2020 Nov;131:110775. doi: 10.1016/j.biopha.2020.110775. Epub 2020 Sep 26.
7
Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613.外泌体通过转运miR-613逆转非小细胞肺癌对顺铂的化疗耐药性
Cancer Manag Res. 2020 Sep 3;12:7961-7972. doi: 10.2147/CMAR.S254310. eCollection 2020.
8
Risk-Based lung cancer screening: A systematic review.基于风险的肺癌筛查:一项系统综述。
Lung Cancer. 2020 Sep;147:154-186. doi: 10.1016/j.lungcan.2020.07.007. Epub 2020 Jul 12.
9
MiR-613 blocked the progression of cervical cancer by targeting LETM1.miR-613 通过靶向 LETM1 抑制宫颈癌的进展。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6576-6582. doi: 10.26355/eurrev_202006_21642.
10
Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.miR-576-3p、miR-613、NDRG2 和 YKL40 在结直肠癌患者中的临床潜力。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1689-1695. doi: 10.31557/APJCP.2020.21.6.1689.